Showing results (161-170 of 366) with videos related to

Sort By:
Pageof 37
Cancer Cell|June 14, 2022
Cancer vaccinesJohn T Schiller, Douglas R Lowy, Ian H Frazer, et al.
Gynecologic Oncology|January 3, 2016
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapySusan M Domchek, Carol Aghajanian, Ronnie Shapira-Frommer, et al.
JCO Precision Oncology|February 26, 2020
Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast CancerAngela R Bradbury, Linda Patrick-Miller, Brian L Egleston, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 19, 2024
Prevalence of H. pylori and Gastric Intestinal Metaplasia in BRCA1 and BRCA2 CarriersBlake A Niccum, Sarah Coughlin, Daniel Clay, et al.
Aging & Mental Health|October 15, 2021
Inflammatory and blood gas markers of COVID-19 delirium compared to non-COVID-19 delirium: a cross-sectional studyAman Saini, Tae Hyun Oh, Dory Anthony Ghanem, et al.
Radiology|July 21, 2007
Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening studyConstance D Lehman, Claudine Isaacs, Mitchell D Schnall, et al.
JCI Insight|April 28, 2026
Comparative analysis of distinct genomic landscapes in young-onset gBRCA1/2 breast cancerMwangala P Akamandisa, Mingyi Xia, Wilson Cheah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancersErica L Carpenter, Rosemarie Mick, Andrew J Rech, et al.
Molecular Genetics & Genomic Medicine|August 4, 2019
Research participants' experiences with return of genetic research results and preferences for web-based alternativesJill B Gaieski, Linda Patrick-Miller, Brian L Egleston, et al.
British Journal of Cancer|December 9, 2022
Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10Rebecca S Kristeleit, Yvette Drew, Amit M Oza, et al.
Pageof 37